News

RP1 Oncolytic Therapy Provides New Hope for Patients Whose Melanoma Resists Conventional Immunotherapy

About half of all patients with advanced melanoma face a poor prognosis because their cancer doesn’t respond to immunotherapy — but results of a recent clinical trial show that an unusual treatment strategy could change that.

News

Myeloma Experts Uncover Key Role for Neutrophils, Potential New Treatment Strategy

Research shows that blocking CXCR2 receptor reduced tumor growth and improved survival; clinical trial underway.

News

Single Dose of Radiation as Effective as 5-Week Course for Lung Cancer: Roswell Park Shares Results at ASTRO

Dr. Mark Farrugia describes new approach to post-operative radiation therapy for non-small cell lung cancer

News

Final Landmark Clinical Trial Data Demonstrates Deep, Durable Responses to Menin Inhibition in Acute Leukemia Patients

Drug application in review based on trial co-led by Roswell Park’s Dr. Eunice Wang in patients with NPM1-mutant AML.

News

Innovative Roswell Park Radiation Therapy Protocol in Lung Cancer to Be Highlighted at ASTRO Annual Meeting

Experts from Roswell Park Comprehensive Cancer Center will share the findings of a novel approach using radiation therapy to treat lung cancer at the American Society for Radiation Oncology (ASTRO) Annual Meeting Sept. 27-Oct. 1, 2025, in San Francisco.

Symposium

Upstate New York Hematology & Hematologic Oncology Conference: A Review of the 66th ASH Annual Meeting

This two-day symposium and lecture series presented an engaging and interactive forum to discuss the latest advances in the fields of benign, malignant and classical hematology and includes speakers from Roswell Park Comprehensive Cancer ...